Concomitant radiotherapy and hyperthermia for primary carcinoma of the vagina: A cohort study

详细信息	查看全文 | 推荐本文 |

• 作者：Mustafa Aktas ; Diederick de Jong ; Joost J. Nuyttens ; Jacoba van der Zee ; Dennis H.M. Wielheesen ; Erdogan Batman ; Curt W. Burger ; Anca C. Ansink
• 关键词：Vagina carcinoma ; Radiotherapy ; Chemotherapy ; Chemoradiation ; Hyperthermia
• 刊名：European Journal of Obstetrics and Gynecology and Reproductive Biology
• 出版年：2007
• 期刊代码：92_03012115
• 类别：med
• 出版时间：July 2007
• 卷：133
• 期：1
• 页码：100-104
• 文件大小：161 K

摘要

To evaluate the supplementary value of adding hyperthermia to radiotherapy in patients with primary vaginal cancer.

Study design

Cohort of 44 patients diagnosed with primary vaginal cancer between 1990 and 2002 was assessed. Survival rates and median survival of patients with primary vaginal cancer undergoing radiotherapy with and without hyperthermia were compared. Hyperthermia was solely added to radiotherapy in case of a tumor size >4 cm in diameter for FIGO stage III disease.

Results

The calculated overall 5-year survival of primary vaginal cancer was 63%. In comparison to histologic high grade tumors, higher survival rates for histologic low grade tumors were calculated. For FIGO stage III of disease, the addition of hyperthermia to radiotherapy for tumors >4 cm in diameter resulted similar survival rates and median survival when compared to those achieved by radiotherapy as monotherapy in tumors of <4 cm in diameter.

Conclusions

The addition of hyperthermia to radiotherapy might result in better survival rates in primary vaginal cancer for tumors >4 cm in diameter. The supplementary effect of hyperthermia to radiotherapy may be a feasible and beneficial approach in the treatment of vaginal cancer.